Charles Rudin

And then during that time...

I got involved in some of the cancer research there and then stayed there for my medical oncology fellowship where I worked with Charlie Rudin.

And that's really where I first got to work in lung cancer specifically.

We worked on a type of lung cancer called K-Rasmutin lung cancer, which is the most common lung cancer study.

Thank you Akshay Patel for highlighting this.

And Charles Rudin is the senior author from Memorial Sloan Kettering.

And yes, they have found the jug, they've smashed it.

So, Tarlatanab is a drug that is working.